Canaccord Genuity reaffirmed their hold rating on shares of LeMaitre Vascular (NASDAQ:LMAT) in a research note issued to investors on Friday morning. The firm currently has a $33.00 target price on the medical instruments supplier’s stock.
Other research analysts have also issued research reports about the stock. BidaskClub upgraded shares of LeMaitre Vascular from a hold rating to a buy rating in a research report on Wednesday, February 7th. Zacks Investment Research raised shares of LeMaitre Vascular from a hold rating to a buy rating and set a $35.00 price target for the company in a report on Tuesday, October 31st. Stifel Nicolaus reaffirmed a buy rating on shares of LeMaitre Vascular in a report on Sunday, October 29th. First Analysis downgraded shares of LeMaitre Vascular from an overweight rating to an equal weight rating and set a $34.00 price target for the company. in a report on Friday, October 27th. Finally, Benchmark downgraded shares of LeMaitre Vascular from a buy rating to a hold rating in a report on Friday, October 27th. Five analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The company currently has a consensus rating of Hold and an average target price of $33.00.
LeMaitre Vascular (NASDAQ LMAT) opened at $35.79 on Friday. LeMaitre Vascular has a 52-week low of $21.52 and a 52-week high of $39.88. The stock has a market cap of $668.22, a P/E ratio of 41.62, a price-to-earnings-growth ratio of 2.43 and a beta of 0.53.
The company also recently declared a quarterly dividend, which will be paid on Thursday, April 5th. Stockholders of record on Thursday, March 22nd will be issued a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.78%. The ex-dividend date of this dividend is Wednesday, March 21st. This is an increase from LeMaitre Vascular’s previous quarterly dividend of $0.06. LeMaitre Vascular’s dividend payout ratio is 25.58%.
Institutional investors have recently modified their holdings of the company. Victory Capital Management Inc. lifted its holdings in shares of LeMaitre Vascular by 181.2% during the 3rd quarter. Victory Capital Management Inc. now owns 4,139 shares of the medical instruments supplier’s stock worth $155,000 after acquiring an additional 2,667 shares during the period. Teachers Retirement System of The State of Kentucky bought a new stake in shares of LeMaitre Vascular during the 2nd quarter worth approximately $137,000. LS Investment Advisors LLC lifted its holdings in shares of LeMaitre Vascular by 41.8% during the 3rd quarter. LS Investment Advisors LLC now owns 4,510 shares of the medical instruments supplier’s stock worth $169,000 after acquiring an additional 1,330 shares during the period. Royal Bank of Canada lifted its holdings in shares of LeMaitre Vascular by 856.5% during the 2nd quarter. Royal Bank of Canada now owns 5,031 shares of the medical instruments supplier’s stock worth $157,000 after acquiring an additional 4,505 shares during the period. Finally, Advisor Group Inc. lifted its holdings in shares of LeMaitre Vascular by 119.1% during the 3rd quarter. Advisor Group Inc. now owns 5,483 shares of the medical instruments supplier’s stock worth $205,000 after acquiring an additional 2,980 shares during the period. 75.04% of the stock is owned by institutional investors.
COPYRIGHT VIOLATION WARNING: This article was first published by Ticker Report and is owned by of Ticker Report. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this article can be viewed at https://www.tickerreport.com/banking-finance/3222748/canaccord-genuity-reiterates-hold-rating-for-lemaitre-vascular-lmat.html.
LeMaitre Vascular Company Profile
LeMaitre Vascular, Inc is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment.
Receive News & Ratings for LeMaitre Vascular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular and related companies with MarketBeat.com's FREE daily email newsletter.